Saul Ewing LLP is pleased to sponsor the upcoming Innovation @ Penn event, "Translating Discovery into Targeted Therapies," held in conjunction with the Penn Center for Innovation at the annual J.P. Morgan Healthcare Conference.
Each year, the Innovation @ Penn program fosters in-depth discussions about the most cutting-edge developments in technology and innovation, and attracts professionals from across the global pharma, medtech and biotech industries. This event is a great opportunity to learn about emerging innovation and explore new areas for research, investment and partnership with Penn.
Related Professionals
